Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Acelrx Pharmaceuticals Inc (ACRX)  
$1.15 0.07 (5.35%) as of 4:30 Thu 5/16


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 8,200,000
Market Cap: 9.43(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.463 - $1.47
Level I Sector: Conglomerates
Level II Sector: Conglomerates
Level III Sector: Conglomerates

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   AcelRx Pharmaceuticals is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Co.'s portfolio of products and product candidates consists of sufentanil sublingual products and product candidates, pre-filled syringe product candidates and nafamostat mesylate product candidates. Co.'s sufentanil sublingual products and product candidates include DSUVIA®, which is indicated for use in adults in supervised healthcare settings; Zalviso®, which is intended for the management of moderate-to-severe acute pain in hospitalized adult patients; and ARX-02, which is for cancer breakthrough pain in opioid-tolerant patients.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 10,000 20,000 66,400
Total Buy Value $0 $7,268 $15,218 $25,551
Total People Bought 0 1 1 1
Total Buy Transactions 0 1 2 3
Total Shares Sold 0 0 16,956 16,956
Total Sell Value $0 $0 $19,235 $19,235
Total People Sold 0 0 1 1
Total Sell Transactions 0 0 2 2
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 271
  Page 3 of 11  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Wan Mark A Director   –       •      –    2022-07-15 4 A $0.00 $0 D/D 15,500 36,750     -
   Bozilenko Marina Director   –       •      –    2022-07-15 4 A $0.00 $0 D/D 15,500 40,500     -
   Adams Adrian Director   –       •      –    2022-07-15 4 A $0.00 $0 D/D 15,500 211,750     -
   Rosen Howard B Director   –       •      –    2022-07-15 4 A $0.00 $0 D/D 15,500 94,250     -
   Hoffman Stephen J Director   –       •      –    2022-07-15 4 A $0.00 $0 D/D 15,500 36,750     -
   Angotti Vincent J. Chief Executive Officer   •       •      –    2022-06-07 4 B $0.22 $10,333 D/D 46,400 1,016,919 2.81 0%     
   Angotti Vincent J. Chief Executive Officer   •       •      –    2022-03-03 4 D $0.41 $9,377 D/D (23,051) 970,519     -
   Dasu Badri N Chief Engineering Officer   •       –      –    2022-03-03 4 D $0.41 $2,283 D/D (5,612) 300,595     -
   Palmer Pamela P Chief Medical Officer   •       •      –    2022-03-03 4 D $0.41 $3,223 D/D (7,923) 779,261     -
   Asadorian Raffi Chief Financial Officer   •       –      –    2022-03-03 4 D $0.41 $3,223 D/D (7,923) 364,205     -
   Angotti Vincent J. Chief Executive Officer   •       •      –    2022-02-11 4 D $0.40 $9,255 D/D (23,058) 983,570     -
   Angotti Vincent J. Chief Executive Officer   •       •      –    2022-02-11 4 A $0.00 $0 D/D 390,000 1,006,628     -
   Asadorian Raffi Chief Financial Officer   •       –      –    2022-02-11 4 D $0.40 $3,182 D/D (7,927) 368,080     -
   Asadorian Raffi Chief Financial Officer   •       –      –    2022-02-11 4 A $0.00 $0 D/D 117,500 376,015     -
   Dasu Badri N Chief Engineering Officer   •       –      –    2022-02-11 4 D $0.40 $2,254 D/D (5,615) 296,207     -
   Dasu Badri N Chief Engineering Officer   •       –      –    2022-02-11 4 A $0.00 $0 D/D 97,500 301,822     -
   Palmer Pamela P Chief Medical Officer   •       •      –    2022-02-11 4 D $0.40 $3,182 D/D (7,927) 777,184     -
   Palmer Pamela P Chief Medical Officer   •       •      –    2022-02-11 4 A $0.00 $0 D/D 122,500 785,111     -
   Palmer Pamela P Chief Medical Officer   •       •      –    2022-02-06 4 D $0.43 $4,049 D/D (9,391) 662,611     -
   Asadorian Raffi Chief Financial Officer   •       –      –    2022-02-06 4 D $0.43 $4,049 D/D (9,391) 258,515     -
   Angotti Vincent J. Chief Executive Officer   •       •      –    2022-02-06 4 D $0.43 $11,780 D/D (27,318) 616,628     -
   Dasu Badri N Chief Engineering Officer   •       –      –    2022-02-06 4 D $0.43 $2,945 D/D (6,830) 204,322     -
   Adams Adrian Director   –       •      –    2021-06-17 4 A $0.00 $0 D/D 10,000 196,250     -
   Afable Richard Director   –       •      –    2021-06-17 4 A $0.00 $0 D/D 10,000 22,250     -
   Wan Mark A Director   –       •      –    2021-06-17 4 A $0.00 $0 D/D 10,000 21,250     -
  271 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 3 of 11
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us